China Resources Medical Holdings Company Limited Capital Reinvestment Ratio
China Resources Medical Holdings Company Limited capital reinvestment ratio. China Resources Medical Holdings Company Limited (1PH) has a Capital Reinvestment Ratio of 0.36x as of June 2023, meaning it reinvests 0% of its operating cash flow (€270.22 Million) in capital expenditures (€96.85 Million). Check China Resources Medical Holdings Company (1PH) total reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Capital Reinvestment Ratio of China Resources Medical Holdings Company Limited (2016–2025)
Capital reinvestment ratio of China Resources Medical Holdings Company Limited from 2016 to 2025. This chart tracks China Resources Medical Holdings Company Limited's Capital Reinvestment Ratio across 10 annual periods. Also explore China Resources Medical Holdings Company (1PH) equity growth momentum to track the company's year-over-year net asset growth rate.
China Resources Medical Holdings Company Limited Capital Reinvestment Ratio by Year (2016–2025)
China Resources Medical Holdings Company Limited capital reinvestment ratio by year from 2016 to 2025. For the full cash flow conversion analysis, see 1PH cash flow conversion.
| Year | Reinvestment Ratio | Operating CF (EUR) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2025 | 0.38x | €1.36 Billion | €514.13 Million | ▼ -14.7% |
| 2024 | 0.44x | €1.27 Billion | €563.69 Million | ▲ +9.0% |
| 2023 | 0.41x | €1.20 Billion | €486.68 Million | ▲ +0.9% |
| 2022 | 0.40x | €626.58 Million | €252.87 Million | ▲ +44.5% |
| 2021 | 0.28x | €710.43 Million | €198.43 Million | ▼ -14.2% |
| 2020 | 0.33x | €643.69 Million | €209.55 Million | ▲ +227.7% |
| 2019 | 0.10x | €366.05 Million | €36.37 Million | ▼ -42.4% |
| 2018 | 0.17x | €334.15 Million | €57.61 Million | ▲ +129.6% |
| 2017 | 0.08x | €459.54 Million | €34.50 Million | ▼ -60.4% |
| 2016 | 0.19x | €223.79 Million | €42.45 Million | — |